Coupled Neuraxial Mesoscopic Desynchronization Therapy for Neural Pathway Modulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current electrostimulatory methods for pain management often result in maladaptive neuroplastic changes and fail to address the underlying clinicopathologic mechanisms, leading to temporary symptom relief rather than true remediation, and lack effective monitoring and treatment protocols.

Innovation Solution

Coupled Neuraxial Mesoscopic Desynchronization Electrostimulation Therapy (cNMDET) uses progressively sequenced electrode placements and patterned applications of Coupled Neuraxial Transcutaneous Electrical Nerve Stimulation (cNTENS) and Coupled Neuraxial Transcranial Direct Stimulation (ctDCSn) to target neural pathways, incorporating priming, preconditioning, and the Neural-Tube Technique for individualized therapeutic modulation, enhancing neurometabolic capacities and addressing maladaptive changes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional electrostimulatory methods are used for pain management, then temporary symptom relief is achieved, but maladaptive neuroplastic changes occur and underlying mechanisms are not addressed

Engineering Contradiction:
Improvetemporary symptom reliefVSAvoidmaladaptive neuroplastic changes
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The method applies preliminary actions (priming and preconditioning phases) before the main therapeutic electrostimulation. Priming involves initial electrode placements and stimulation parameters to prepare the neural pathways, while preconditioning establishes baseline measurements and adjusts parameters. This preliminary action prevents maladaptive changes by properly preparing the nervous system for the therapeutic intervention, ensuring that the underlying mechanisms are addressed rather than merely masking symptoms.

Inventive Principle:
Principle #10Preliminary action

2Reliability

If electrostimulation targets only local pain areas, then local symptom relief is achieved, but underlying neural pathway mechanisms are not addressed

Engineering Contradiction:
Improvelocal symptom reliefVSAvoidunderlying mechanism information
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The method transitions from two-dimensional local electrode placement to a three-dimensional approach by incorporating multiple electrode placements along the entire neural pathway from the periphery through the spinal cord to the brain. This dimensional expansion allows simultaneous targeting of local pain areas and the underlying central nervous system mechanisms, preserving information about the full extent of neural involvement while achieving comprehensive symptom relief.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Ease of operation

If fixed electrostimulation parameters are used, then treatment simplicity is maintained, but individualized therapeutic needs are not met

Engineering Contradiction:
Improvetreatment simplicityVSAvoidindividualized therapeutic modulation
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The method employs dynamic treatment protocols where electrode placements, stimulation parameters (intensity, frequency, pulse width), and treatment duration are progressively adjusted based on patient response and therapeutic progress. The protocol evolves through multiple phases (priming, preconditioning, treatment) with parameters modified in subsequent sessions to optimize individualized therapeutic effects while maintaining operational simplicity through structured progression guidelines.

Inventive Principle:
Principle #15Dynamics

4Reliability

If comprehensive neural pathway targeting is implemented, then true remediation is achieved, but treatment complexity increases

Engineering Contradiction:
Improvetrue remediationVSAvoidelectrode placement and protocol complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The complex neural pathway targeting is segmented into distinct anatomical regions (peripheral nerves, spinal cord segments, brain regions) and temporal phases (priming, preconditioning, treatment). Each segment has specific electrode placement guidelines and stimulation parameters, breaking down the overall complex protocol into manageable, standardized components that can be systematically applied while achieving comprehensive true remediation.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

cNMDET achieves sustained reparative modulation of the CNS and PNS, targeting etiotropic changes and enhancing neurometabolic capacities, providing effective pain relief for a broad range of diagnostic entities with reduced risk of maladaptive effects.

Implementation Method 1

therapeutic electrostimulation method... to apply this therapeutic electrostimulation along the coursing path (longitudinally) of the targeted neural pathway

Methodology Applied
Scientific EffectElectrical stimulation: Conduction (electrical)

Data Source

PatentUS8428738B2Coupled neuraxial mesoscopic desynchronization electrostimulation therapy (cNMDET) method
Publication Date: 2013.04.23 VALENCIA ANDREW D
  • US8428738B2 patent drawing
  • US8428738B2 patent drawing
  • US8428738B2 patent drawing

AI summary

This novel therapeutic (reparative, etiotropic not merely symptomatolytic) electrostimulatory method hereinafter referred to as Coupled Neuraxial Mesoscopic Desynchronization Electrostimulation Therapy (cNMDET) is comprised of a varied combination of progressively sequenced electrode placements and its clinically targeted areas which are comprised of the CNS [regions of the brain and spinal cord including, but not limited to, the underlying clinicopathologic mechanisms of the ANS] and clinically involved components of the PNS variably coupled in such a manner as to apply this therapeutic electrostimulation (reparative modulation) along the coursing path (longitudinally) of the targeted neural pathway over a segment and/or in its entirety, as well as, the utilization of patterned applications for involved joints, muscles, fascia, ligaments, tendons and areas involved in inflammatory processes of clinical significance accomplished through the application of, preferably, but not limited to, Coupled Neuraxial Transcutaneous Electrical Nerve Stimulation (cNTENS) and Coupled Neuraxial Transcranial Direct Stimulation (ctDCSn).